Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project.
D000328:Adult; D000880:Anthraquinones / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone
D000880:Anthraquinones; D008942:Mitoxantrone